- Landos Biopharma ( NASDAQ: LABP ) announced a $16.7M private placement financing from the sale of pre-funded warrants to purchase an aggregate of 30.9M shares at a price per pre-funded warrant of $0.54 to entities associated with Perceptive Advisors, Landos’ largest stockholder.
- The price per pre-funded warrant was based on the closing price per share on January 4, 2023.
- Gross proceeds from the financing total ~$16.7M million.
- Closing is expected to close on or before January 10, 2023.
For further details see:
Landos Biopharma announces $16.7M private placement